- Centers & Specialties
- Clinical Interests
- Acute coronary syndromes
- Interventional cardiology
- Intravascular Imaging
- Medical Education
- MD, Kyung Hee University
- Residency, University Hospital Belgium
- Fellowship, Massachusetts General Hospital|Fellowship, University Hospital Belgium
- Board Certifications
- Cardiovascular Disease
- Interventional Cardiology
- Foreign Languages
- Boston: Massachusetts General Hospital
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - other
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Medicare - ACD
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
A recipient of the Partners in Excellence Award for Research in 2000 and for leadership in 2006, his research roster is extensive, and is focused on acute coronary syndromes including acute myocardial infarction. His earlier research focused on pharmacology and physiology of thrombosis and thrombolysis. In 1994 he extended his interests to clinical studies. Since founding the Coronary Clinical Trial Group within the Cardiac Unit in 1995, he has conducted numerous clinical studies. He also led Clinical Research Office of the Cardiology Division between 2003 and 2006. He is currently the Director of the Cardiology Laboratory for Integrative Physiology and Imaging (CLIPI).
For the last eleven years he has pioneered the application of intravascular Optical Coherence Tomography (OCT) to patients to better characterize vulnerable plaque and to understand the mechanisms of plaque rupture. Dr. Jang has been invited to lectures at numerous national and international meetings. His publications number more than 200.
- Research Summary
- Summary: Dr. Jang's research focus has evolved from the pathogenesis and improved management of acute myocardial infarction to the prevention of acute coronary syndromes and sudden cardiac death. His research contributions include:
- Demonstrating the crucial role of platelets in the sensitivity of the thrombus to thrombolysis. His work provides the groundwork for future research of platelet inhibition therapy for acute coronary syndromes
- Demonstrating the role of thrombin in thrombosis and thrombolysis, and validating the thrombin hypothesis
- Organizing and conducting the international, multicenter clinical studies as a principal investigator to improve the treatment of patients with acute myocardial infarction
- Pioneering a new field of detection of vulnerable coronary plaques using optical coherence tomography (OCT)
Dr. Jang has published over 200 publications.
MGH patient encourages CPR training following near-death experience.
MGH Hotline 04.09.10 Optical coherence tomography (OCT) is an intravascular imaging technology that offers the promise of revealing the microscopic characteristics of a vulnerable coronary plaque.
Massachusetts General Hospital to create international registry for coronary optical coherence tomography
Mass General researchers are spearheading an international effort to study optical coherence tomography (OCT), an imaging technology that could help doctors identify the vulnerable coronary plaques that cause heart attacks.
Mass General researchers use optical coherence tomography to identify vulnerable coronary plaques
Mass General researchers are spearheading an international effort to study optical coherence tomography (OCT), an imaging technology that could help doctors identify the vulnerable coronary plaques that cause heart attacks. By creating extremely high-resolution images from within the artery, OCT can pinpoint the microscopic characteristics of a vulnerable plaque.
55 Fruit Street
Boston, MA 02114